Skip to main content
Equibles

Soleus Capital Management, L.P.

Position in IVVD — Invivyd, Inc.

CIK 1802630 GREENWICH, CT
Back to IVVD Full portfolio

Position in IVVD

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$6,722,009
-$3,299,336 QoQ
Shares Held
7,708,727
0.0% QoQ
Ownership
2.62%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#9
of 124 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IVVD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Soleus Capital Management, L.P. holds $1,753,981,438 across 64 Biotechnology names. IVVD ranks #46 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 KRYS
Krystal Biotech, Inc.
 939,254 $349,092,534
2 CELC
Celcuity Inc.
 1,704,318 $178,305,749
3 TGTX
Tg Therapeutics, Inc.
 2,927,895 $160,858,551
4 RIGL
Rigel Pharmaceuticals Inc
 1,843,504 $72,117,876
5 VCEL
Vericel Corp
 1,459,152 $64,917,672
6 PRAX
Praxis Precision Medicines, Inc.
 177,517 $59,430,916
7 GERN
Geron Corp
 42,808,659 $54,795,083
8 ERAS
Erasca, Inc.
 2,700,000 $49,464,000

All Filings in IVVD

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,722,009 7,708,727
2026-03-31 $10,021,345 7,708,727
2025-12-31 $19,040,555 7,708,727